SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001479290-23-000028
Filing Date
2023-02-28
Accepted
2023-02-28 16:22:27
Documents
113
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rvnc-20221231.htm   iXBRL 10-K 3367012
2 EX-4.4 ex_44xdescriptionsofsecuri.htm EX-4.4 30845
3 EX-10.12 ex_1012x2014inducementplan.htm EX-10.12 68179
4 EX-10.31 ex_1031xmanagementbonuspla.htm EX-10.31 6340
5 EX-10.46 ex_1046xteoxanesathirdamen.htm EX-10.46 27255
6 EX-23.1 ex_231xpublicaccountingfir.htm EX-23.1 2289
7 EX-31.1 ex_311xcertificationofpeox.htm EX-31.1 8212
8 EX-31.2 ex_312xcertificationofpfox.htm EX-31.2 8309
9 EX-32.1 ex_321xcertificationofpeox.htm EX-32.1 5632
10 EX-32.2 ex_322xcertificationofpfox.htm EX-32.2 5684
16 rvnc-20221231_g1.jpg GRAPHIC 125637
17 rvnc-20221231_g2.jpg GRAPHIC 272307
  Complete submission text file 0001479290-23-000028.txt   14926502

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20221231.xsd EX-101.SCH 77340
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20221231_cal.xml EX-101.CAL 153178
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20221231_def.xml EX-101.DEF 480364
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20221231_lab.xml EX-101.LAB 1042666
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20221231_pre.xml EX-101.PRE 732629
107 EXTRACTED XBRL INSTANCE DOCUMENT rvnc-20221231_htm.xml XML 2324706
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36297 | Film No.: 23685795
SIC: 2834 Pharmaceutical Preparations